Testing effectiveness (Phase 2)Study completedNCT00000625
What this trial is testing
A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 2,100